Co-found companies based on new technologies
Acquisition, Development and out-licensing
Avadel looks to grow its portfolio through internal development and by acquiring or in-licensing new products. The company currently markets products in both the primary care and sterile ...
Bringing specialty pharmaceuticals to Canada
Contracts with western companies to bring them to Asian markets
Company acquires rare disease products moves forward then spins out companies
Dova is a clinical-stage pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is a high unmet medical need.
Royalty Management Company
Acquisition for Chinese Development
in-licensing drugs & device technologies
Acquisition & Licensing of Small Molecules and Devices
Acquisition & Development of cancer drugs
Puma Biotechnology focuses on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then ...
Acquiring Many Small Molecules
Licensing Western products to sell in Asia
Marketing producs in Australia
Acquisition & Accelerated Development
In-licensing of medical aesthetics in dermatology
In-licensing of clinical oncology products
Acquisition & Advancement of Biologics
Acquisition & Commercialization